These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34914104)
1. The "Coming of Age" of Real-World Evidence in Drug Development and Regulation. Honig PK Clin Pharmacol Ther; 2022 Jan; 111(1):11-14. PubMed ID: 34914104 [TBL] [Abstract][Full Text] [Related]
2. Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018-2019. Eskola SM; Leufkens HGM; Bate A; De Bruin ML; Gardarsdottir H Clin Pharmacol Ther; 2022 Jan; 111(1):310-320. PubMed ID: 34689334 [TBL] [Abstract][Full Text] [Related]
3. Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation. Breckenridge AM; Breckenridge RA; Peck CC Br J Clin Pharmacol; 2019 Sep; 85(9):1874-1877. PubMed ID: 31290181 [TBL] [Abstract][Full Text] [Related]
4. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Miksad RA; Abernethy AP Clin Pharmacol Ther; 2018 Feb; 103(2):202-205. PubMed ID: 29214638 [TBL] [Abstract][Full Text] [Related]
5. Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy. Turner MA; Portman RJ; Davis JM JAMA Pediatr; 2017 Aug; 171(8):721-722. PubMed ID: 28604936 [No Abstract] [Full Text] [Related]
6. Use of real-world evidence for oncology clinical decision making in emerging economies. Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583 [TBL] [Abstract][Full Text] [Related]
7. Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World. McNair D; Lumpkin M; Kern S; Hartman D Clin Pharmacol Ther; 2022 Jan; 111(1):44-51. PubMed ID: 34655224 [TBL] [Abstract][Full Text] [Related]
8. [The application of real-world evidence in drug regulatory decision-making]. Wicherski J; Haenisch B Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Feb; 67(2):149-154. PubMed ID: 38214723 [TBL] [Abstract][Full Text] [Related]
9. How can real-world evidence aid decision making during the life cycle of nonprescription medicines? Csoke E; Landes S; Francis MJ; Ma L; Teotico Pohlhaus D; Anquez-Traxler C Clin Transl Sci; 2022 Jan; 15(1):43-54. PubMed ID: 34405554 [TBL] [Abstract][Full Text] [Related]
10. Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World. Burns L; Roux NL; Kalesnik-Orszulak R; Christian J; Hukkelhoven M; Rockhold F; O'Donnell J Clin Ther; 2022 Mar; 44(3):420-437. PubMed ID: 35181179 [TBL] [Abstract][Full Text] [Related]
11. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions. Wu J; Wang C; Toh S; Pisa FE; Bauer L Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065 [TBL] [Abstract][Full Text] [Related]
12. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project. Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454 [TBL] [Abstract][Full Text] [Related]
13. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness. Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318 [TBL] [Abstract][Full Text] [Related]
14. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation? Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S F1000Res; 2018; 7():111. PubMed ID: 30026923 [TBL] [Abstract][Full Text] [Related]
15. Examining the Use of Real-World Evidence in the Regulatory Process. Beaulieu-Jones BK; Finlayson SG; Yuan W; Altman RB; Kohane IS; Prasad V; Yu KH Clin Pharmacol Ther; 2020 Apr; 107(4):843-852. PubMed ID: 31562770 [TBL] [Abstract][Full Text] [Related]
16. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making. Klonoff DC J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738 [TBL] [Abstract][Full Text] [Related]
17. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact. Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702 [TBL] [Abstract][Full Text] [Related]
18. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430 [TBL] [Abstract][Full Text] [Related]
19. Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential. Liu Q; Zhu H; Liu C; Jean D; Huang SM; ElZarrad MK; Blumenthal G; Wang Y Clin Pharmacol Ther; 2020 Apr; 107(4):726-729. PubMed ID: 31925955 [No Abstract] [Full Text] [Related]
20. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives. Clausen M; Mighton C; Kiflen R; Sebastian A; Dai WF; Mercer RE; Beca JM; Isaranuwatchai W; Chan KKW; Bombard Y CMAJ Open; 2020; 8(4):E772-E778. PubMed ID: 33234584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]